SCHEMBL13245019

SCHEMBL13245019

O=C(O)c1ccc(C#CC#Cc2ccc(CO)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.48
RARB P10826 2/20 0.47
RARG P13631 2/20 0.47
ALDH1A1 P00352 1/20 0.47
PTPN11 Q06124 1/20 0.45
TSHR P16473 2/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
FFAR1 O14842 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.41
RXRA P19793 3/20 0.40
RXRB P28702 3/20 0.40
NR4A2 P43354 2/20 0.40
SRD5A2 P31213 1/20 0.40
MMP2 P08253 1/20 0.40
MMP12 P39900 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254253 0.92 RARB (0.55) ACACBRARBRARGALDH1A1PTPN11
SCHEMBL2679567 0.86 TSHR (0.60) ACACBRARBRARGALDH1A1PTPN11
SCHEMBL49984 0.84 TSHR (0.63) ALDH1A1TSHRTP53SMN1; SMN2NPC1
Terephthalic Acid SCHEMBL28453225 0.84 TSHR (0.63) ALDH1A1TSHRTP53SMN1; SMN2NPC1
Terephthalic Acid SCHEMBL28358133 0.84 TSHR (0.63) ALDH1A1TSHRTP53SMN1; SMN2NPC1
SCHEMBL15251986 0.82 TSHR (0.60) ALDH1A1TSHRTP53SMN1; SMN2NPC1
Ammonia Solution, Strong SCHEMBL11061336 0.82 TSHR (0.60) ALDH1A1TSHRTP53SMN1; SMN2NPC1
SCHEMBL10570096 0.82 TSHR (0.60) ALDH1A1TSHRTP53SMN1; SMN2NPC1
SCHEMBL16820923 0.81 MMP2 (0.51) ACACBRARBRARGALDH1A1PTPN11
SCHEMBL402852 0.80 TSHR (0.54) RARBRARGPTPN11TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349544-A1 Ethynylbenzene Derivatives DUKE UNIVERSITY 2017-12-07 US disclosed
US-20170349544-A1 Ethynylbenzene Derivatives DUKE UNIVERSITY 2017-12-07 US disclosed
US-9738604-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2017-08-22 US disclosed
US-9738604-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2017-08-22 US disclosed
US-9617256-B2 Antibacterial agents ACHAOGEN, INC. (US) 2017-04-11 US disclosed
EP-2170814-B1 ANTIBACTERIAL AGENTS ACHAOGEN INC (US) 2016-08-17 EP disclosed
EP-2662353-A2 Antibacterial agents Achaogen, Inc. (US) 2013-11-13 EP disclosed
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2013-09-05 US disclosed
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2013-09-05 US disclosed
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 US disclosed
WO-2008154642-A2 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190766-A1 ANTIBACTERIAL AGENTS MRPL21, SI, ABCB11 ACACB 3224/4885RARB 1644/4885RARG 2102/4885
US-20170349544-A1 Ethynylbenzene Derivatives Q6ZSR9, EPX, ZYX ACACB 2488/4885RARB 1630/4885RARG 2938/4885
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES Q6ZSR9, EPX, ZYX ACACB 2488/4885RARB 1630/4885RARG 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.